Autoimmune and inflammatory manifestations associated with acute myeloid leukemia with Trisomy 8—Case series and review of the literature-Reference-Cited by-同舟云学术

Autoimmune and inflammatory manifestations associated with acute myeloid leukemia with Trisomy 8—Case series and review of the literature

Published:2021-12-21 Issue:3 Volume:108 Page:199-203
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:European J of Haematology

Author:

Buchrits Shira¹²,Kozlovoski Dror¹²,Gafter‐Gvili Anat¹²³,Raanani Pia²³,Hayman Lucille⁴,Revyako Igor⁴,Bernstine Hanna²⁵,Wolach Ofir²³,Shimony Shai²³

Affiliation:

1. Internal Medicine Department A Rabin Medical Center Beilinson Hospital Petah‐Tikva Israel

2. Sackler Faculty of Medicine Tel Aviv University Tel‐Aviv Israel

3. Institute of Haematology Davidoff Cancer Center Rabin Medical Center Beilinson Hospital Petah‐Tikva Israel

4. Pathology Department Rabin Medical Center Beilinson Hospital Petah Tikva Israel

5. Nuclear Medicine Department Rabin Medical Center Beilinson Hospital Petah Tikva Israel

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13725

Reference15 articles.

1. Autoimmunity and Inflammation in Myelodysplastic Syndromes

2. Trisomy 8 in acute myeloid leukemia

3. A reappraisal of the association between Behçet's disease, myelodysplastic syndrome and the presence of trisomy 8: a systematic literature review;Esatoglu SN;Clin Exp Rheumatol,2015

4. Inflammatory disorders associated with trisomy 8‐myelodysplastic syndromes: French retrospective case‐control study

5. High incidence of gastrointestinal ulceration and cytogenetic aberration of Trisomy 8 as typical features of Behçet's disease associated with myelodysplastic syndrome: a series of 16 consecutive Chinese patients from the Shanghai Behçet's disease database and comparison with the literature;Shen Y;Biomed Res Int,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antineoplastic;Reactions Weekly;2022-05